FOLFOX / FOLFIRI - kurz und bündig

Publisher： Karger

E-ISSN： 2296-5386|4|1|I-I

ISSN： 2296-5416

Source： Karger Kompass Onkologie, Vol.4, Iss.1, 2017-03, pp. : I-I

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Laparoskopische anteriore Rektopexie bei Vollwand-Rektumprolaps bei 175 konsekutiven Patienten: Kurz- und Langzeit-Follow-up

By Kneist W.  

coloproctology, Vol. 36, Iss. 2, 2014-04 ,pp. : 123-124

Springer Publishing Company

Access to resources Recommend Favorite

Kommentar zur Bewertung des Einsatzes kurz wirksamer Insulinanaloga bei Typ-I-Diabetikern durch das Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)

By Wehling M.  

Der Diabetologe, Vol. 3, Iss. 5, 2007-09 ,pp. : 372-379

Springer Publishing Company

Access to resources Recommend Favorite

FOLFIRI Is Tolerable after Subtotal Colectomy – A Patient with Familial Adenomatous Polyposis Who Developed Advanced Rectal Cancer

By  

Case Reports in Gastroenterology, Vol. 1, Iss. 1, 2007-12 ,pp. : 174-177

Karger

Access to resources Recommend Favorite

FOLFIRI Combined with Bevacizumab as First-Line Treatment for Metastatic Colorectal Cancer Patients with Hyperbilirubinemia after UGT1A1 Genotyping

By  

Medical Principles and Practice, Vol. 23, Iss. 5, 2014-03 ,pp. : 478-481

Karger

Access to resources Recommend Favorite

Metastatic Colorectal Cancer with Severe Liver Dysfunction Successfully Treated Using FOLFOX Therapy

By Shimura Takaya  

Journal of Gastrointestinal Cancer, Vol. 42, Iss. 1, 2011-03 ,pp. : 68-72

Springer Publishing Company

Access to resources Recommend Favorite